. Author manuscript; available in PMC: 2018 Aug 30.

Published in final edited form as: Stat Med. 2017 Jun 5;36(19):3059–3074. doi: 10.1002/sim.7344

Table 4.

Confidence Intervals for AAPC over [c, d]

	Joinpoint estimates	[c, d]	AAPC	95% CI for AAPC
	Joinpoint estimates	[c, d]	AAPC	mCCI	FLT	EmpQ
Prostate Incidence (White male)	88, 92, 95, 01	[2006, 2010] [2001, 2010]	−2.535 −2.535	(−3.428, −1.633)^* (−3.428, −1.633)^*	(−3.428, −1.633)^* (−3.476, −1.585)^*	(−4.282, −1.709)^* (−3.161, −1.676)^*
Prostate Incidence (Black male)	89, 92	[2006, 2010] [2001, 2010]	−1.830 −1.830	(−2.160, −1.499)^* (−2.160, −1.499)^*	(−2.160, −1.499)^* (−2.160, −1.499)^*	(−2.160, −1.526)^* (−2.160, −1.526)^*
Breast Incidence (White female)	80, 87, 94, 99, 04	[2006, 2010] [2001, 2010]	−0.056 −0.831	(−0.858, 0.752) (−1.512, −0.146)^*	(−0.858, 0.752) (−1.165, −0.497)^*	(−0.631, 0.854) (−1.142, −0.518)^*
Pancreas Incidence (Male: All races)	93, 03, 08	[2001, 2010]	0.610	(−1.011, 2.257)	(0.069, 1.154)^*	(0.111, 1.311)^*
Non-Hodgkin Lymphoma (Blacks: Both sexes)	93	[2001, 2010]	0.640	(0.010, 1.275)^*	(0.010, 1.275)^*	(−0.577, 1.339)

• ^*: significant at 0.05 level of significance

• mCCI: modified conditional confidence interval; FLT: First-Last t-confidence interval; EmpQ: Empitical qantile method confidence itnerval